UBS raised the firm’s price target on Altria Group (MO) to $67 from $63 and keeps a Buy rating on the shares. Risks, including concerns around combustible volume mix, duty drawback benefits, and declining nicotine pouch volumes, are manageable, the analyst tells investors in a research note. Despite slower smoke-free progress, Altria is positioned to return to revenue growth and accelerate EPS in 2026-2027, the firm says.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MO:
- Options Volatility and Implied Earnings Moves This Week, January 26 – January 30, 2026
- The Week That Was, The Week Ahead: Macro and Markets, Jan. 25
- Altria Group call volume above normal and directionally bullish
- Altria Group upgraded to Buy from Neutral at UBS
- Altria Group: Improving Fundamentals, EPS Acceleration, and Discounted Valuation Support Buy Rating